Ftse Mib
33.629,21
-0,32%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
64.184,91
2,06%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Cue Biopharma Inc (CUE) Cue Biopharma Inc (CUE) Notizie

Cue Biopharma Inc

CUE
2,13
0,25 (13,30%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
24/4/202416:01GLOBECue Biopharma to Present at the 2024 American Society of..
08/4/202422:05GLOBECue Biopharma Reports Fourth Quarter and Full Year 2023..
02/4/202414:00GLOBECue Biopharma to Host Business Update Call and Webcast
08/3/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:00GLOBECue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured..
22/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202414:00GLOBECue Biopharma to Present Corporate Update at the..
04/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202314:00GLOBECue Biopharma to Present at the JMP Securities Hematology..
09/11/202322:05GLOBECue Biopharma Reports Third Quarter 2023 Financial Results..
07/11/202314:00GLOBECue Biopharma to Present at Three Upcoming Investor..
03/11/202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202317:00GLOBECue Biopharma Presents New Positive Data from Phase 1 Trials..
02/11/202313:00GLOBECue Biopharma to Host Business Update Call and Webcast
27/9/202315:05GLOBECue Biopharma Announces Upcoming Scientific Presentations at..
26/9/202314:00GLOBECue Biopharma Announces Completion of Patient Enrollment in..
14/9/202322:01EDGAR2Form 8-K - Current report
29/8/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:10GLOBECue Biopharma Reports Second Quarter 2023 Financial Results..
08/8/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202314:00GLOBECue Biopharma to Host Business Update Call and Webcast
25/7/202318:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202318:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202318:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202318:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202314:00GLOBECue Biopharma to Present at the Federation of Clinical..
07/6/202314:00GLOBECue Biopharma to Host Investor Call
05/6/202314:00GLOBECue Biopharma to Present at the Jefferies 2023 Global..
25/5/202323:00GLOBECue Biopharma Presents Positive Data Update from Ongoing..
15/5/202314:00GLOBECue Biopharma to Present at the 2023 American Society of..
09/5/202322:35GLOBECue Biopharma Reports First Quarter 2023 Financial Results..
08/5/202314:00GLOBECue Biopharma to Present at the Upcoming JMP Securities Life..
Apertura: 1,90 Min: 1,87 Max: 2,19
Chiusura: 1,88

La tua Cronologia

NASDAQ
CUE
Cue Biopharma
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network